Abstract:Metersky et al 1 present compelling evidence that adverse events (AEs), including medication errors and hospital-acquired infections (HAIs), increased among patients both with and without COVID-19 during weeks in which hospitals experienced greater COVID-19 admission burdens during the COVID-19 pandemic. The risk of AEs increased 9% with each 10% increase in COVID-19 burden, defined as the daily mean number of COVID-19 inpatients per 100 hospital beds. The investigation by Metersky et al 1 improved on the methods of existing work through its use of hospital-specific COVID-19 admissions data (rather than regional or aggregate hospital data) from the US Department of Health and Human Services (HHS) and its reliance on systematically adjudicated AEs from the Agency for Healthcare Research and Quality. The authors concluded with the recommendation to build more resilient systems of care to maintain patient safety during times of surge capacity. Indeed, these conclusions are well supported by the authors' approach and analysis, and this represents a public health call to action in the US to avoid excess morbidity and mortality in the future. However, still absent from the peer-reviewed literature is a discussion of the importance of hospital quality performance reporting and benchmarking in times of crisis as a mechanism to ensure safety. Hospitals in the US were effectively relieved of their obligations to provide high-quality pandemic-era care when pay-for-performance programs, 2 rankings, 3 and ratings 4 excluded months of pandemic-era data from their methods. Though ostensibly made with benign intent, these decisions to exclude pandemic-era quality-reporting data were not patient centered and may not have been methodologically necessary. 5 ,6 The findings of Metersky et al 1 demonstrate that quality and safety data are needed more than ever during times of crisis. This would allow patients and payers to understand which hospitals have resilient systems in order to make informed decisions about where they choose to receive and fund health care. For example, while Metersky et al 1 found only small differences in fall rates for patients without COVID-19 across hospitals with varying COVID-19 burden, a dose-response association was observed between increasing COVID-19 burdens and HAIs. We may therefore infer differences in systems and processes for fall prevention that allowed for greater resilience than systems and processes for prevention of HAIs. Logically, we could then consider whether exclusion of pandemic-era falls data from hospital-quality reporting was necessary. Exploring these nuances will be critical to identify where resilience in safety is lacking and to build resilience for the future. This may require the creation of pandemic-specific resilience action plans and self-reporting requirements by accrediting bodies, analogous to recent Joint Commission requirements for the reduction of health care disparities. Individual hospitals almost certainly varied in the specific domains of quality that were most and least resilient during the pandemic. Each hospital's least resilient system may represent low-hanging fruit or a starting point for building resilience. To date, however, finding these opportunities to build resilience has been a difficult task, in part due to the exclusion of pandemic-era benchmarking data. Ask chief quality officers to select any 3 among the hundreds of publicly reported quality measures (30-day readmissions, 30-day mortality, falls, HAIs, pressure ulcers, and so on) at which they believe their institution performed the worst during the pandemic, and you will likely get dozens of different answers. For many, the most truthful answer may be "I do not know," which hinders the ability to prioritize improvement. For example, if you knew that the 30-day hospital-wide readmissions rate had dropped from the 90th percentile of national performance to the 20th percentile of performance during the pandemic, there would be an important opportunity to consider which aspects of resilience specific to readmissions at your institution required improvement. With hospital-specific COVID-19 admissions data from HHS coupled with patient-level Medicare or other electronic health record or claims data, it is still possible to recreate the unreported pandemic-era quality outcomes benchmarks to identify resilient hospitals, systems, and processes during surge capacity. In fact, the Centers for Medicare & Medicaid Services' FY 2025 Inpatient Prospective Payment System Proposed Rule will extend the COVID-19 admissions data to include data for all respiratory illnesses. This will allow for the inclusion of future pandemic-era data in quality reporting using risk adjustment for hospitals' respiratory illness admission burdens rather than excluding months or years -Abstract Truncated-

Incorporating Acute Conditions into Risk-Adjustment for Provider Profiling: The Case of the US News and World Report Best Hospitals Rankings Methodology

Assessing Hospital Performance After Percutaneous Coronary Intervention Using Big Data

Assessment of the Effect of Adjustment for Patient Characteristics on Hospital Readmission Rates: Implications for Pay for Performance

Can Adding Laboratory Values Improve Risk-Adjustment Mortality Models Using Clinical Percutaneous Cardiac Intervention Registry Data?

Impact of Risk Adjustment for Socioeconomic Status on Risk-adjusted Surgical Readmission Rates.

Clinical utility gains from incorporating comorbidity and geographic location information into risk estimation equations for atherosclerotic cardiovascular disease

Social Risk Adjustment In The Hospital Readmissions Reduction Program: A Systematic Review And Implications For Policy

The mechanics of risk adjustment and incentives for coding intensity in Medicare

A population health approach to reducing observational intensity bias in health risk adjustment: cross sectional analysis of insurance claims

The measure and mismeasure of hospital quality: appropriate risk-adjustment methods in comparing hospitals

A Simple Risk Adjustment for Hospital-Level Nulliparous, Term, Singleton, Vertex, Cesarean Delivery Rates and Its Implications for Public Reporting

Comparing potentially avoidable hospitalization rates related to ambulatory care sensitive conditions in Switzerland: the need to refine the definition of health conditions and to adjust for population health status

Hospital quality reporting in the pandemic era: to what extent did hospitals’ COVID-19 census burdens impact 30-day mortality among non-COVID Medicare beneficiaries?

Accuracy of hospital report cards based on administrative data

Abstract 9851: Mortality and Post-Discharge Acute Care Utilization for Cardiovascular Conditions at US Safety-Net and Non-Safety-Net Hospitals

Association of the New Peer Group–Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program

Impact of case-mix on comparisons of patient-reported experience in NHS acute hospital trusts in England

Evaluating equity in performance of an electronic health record-based 6-month mortality risk model to trigger palliative care consultation: a retrospective model validation analysis

Lessons in Quality and Safety From Hospitals' COVID-19 Burdens

Catheterization for Congenital Heart Disease Adjustment for Risk Method II

Unplanned Hospital Admissions Stratification Model With Heart Failure Metrics: A Novel Approach For Measuring Disease Progression